IL-6 Inhibitors Market, Global Outlook and Forecast 2022-2028

January 2022 | 69 pages | ID: IF0D8304F6D8EN
Market Monitor Global

Abstracts

IL-6 Inhibitors, which are now considered as promising treatment for COVID-19, target the IL-6 receptors (IL-6Rs), thereby preventing the binding of IL-6 ligands to IL-6 receptors. Thus, inhibiting the entire IL-6 signal transduction . The Interleukin 6 (IL-6) family is a large and diverse group of cytokines (IL-6, IL-11, IL-27, IL-31, OSM, LIF, CNTF, CT-1 and CLCF1) that is defined based on the use of common ?-receptor signaling subunits, which could induce fever in patients

This report contains market size and forecasts of IL-6 Inhibitors in Global, including the following market information:

Global IL-6 Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global IL-6 Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

IL-6 Receptors Antagonistic Anitibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of IL-6 Inhibitors include Roche, Regeneron Pharmaceuticals Inc., Sanofi, Janssen Global Services LLC, Novimmune SA and UCB Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IL-6 Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global IL-6 Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global IL-6 Inhibitors Market Segment Percentages, by Type, 2021 (%)

• IL-6 Receptors Antagonistic Anitibody
• Antibody against IL-6

Global IL-6 Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global IL-6 Inhibitors Market Segment Percentages, by Application, 2021 (%)

• Autoimmune Diease Treatment
• Ajuvant Cancer Treatment
• COVID-19 Therapy

Global IL-6 Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global IL-6 Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies IL-6 Inhibitors revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies IL-6 Inhibitors revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Regeneron Pharmaceuticals Inc.
• Sanofi
• Janssen Global Services LLC
• Novimmune SA
• UCB Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 IL-6 Inhibitors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global IL-6 Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IL-6 INHIBITORS OVERALL MARKET SIZE

2.1 Global IL-6 Inhibitors Market Size: 2021 VS 2028
2.2 Global IL-6 Inhibitors Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top IL-6 Inhibitors Players in Global Market
3.2 Top Global IL-6 Inhibitors Companies Ranked by Revenue
3.3 Global IL-6 Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 IL-6 Inhibitors Companies in Global Market, by Revenue in 2021
3.5 Global Companies IL-6 Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 IL-6 Inhibitors Players in Global Market
  3.6.1 List of Global Tier 1 IL-6 Inhibitors Companies
  3.6.2 List of Global Tier 2 and Tier 3 IL-6 Inhibitors Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global IL-6 Inhibitors Market Size Markets, 2021 & 2028
  4.1.2 IL-6 Receptors Antagonistic Anitibody
  4.1.3 Antibody against IL-6
4.2 By Type - Global IL-6 Inhibitors Revenue & Forecasts
  4.2.1 By Type - Global IL-6 Inhibitors Revenue, 2017-2022
  4.2.2 By Type - Global IL-6 Inhibitors Revenue, 2023-2028
  4.2.3 By Type - Global IL-6 Inhibitors Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global IL-6 Inhibitors Market Size, 2021 & 2028
  5.1.2 Autoimmune Diease Treatment
  5.1.3 Ajuvant Cancer Treatment
  5.1.4 COVID-19 Therapy
5.2 By Application - Global IL-6 Inhibitors Revenue & Forecasts
  5.2.1 By Application - Global IL-6 Inhibitors Revenue, 2017-2022
  5.2.2 By Application - Global IL-6 Inhibitors Revenue, 2023-2028
  5.2.3 By Application - Global IL-6 Inhibitors Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global IL-6 Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global IL-6 Inhibitors Revenue & Forecasts
  6.2.1 By Region - Global IL-6 Inhibitors Revenue, 2017-2022
  6.2.2 By Region - Global IL-6 Inhibitors Revenue, 2023-2028
  6.2.3 By Region - Global IL-6 Inhibitors Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America IL-6 Inhibitors Revenue, 2017-2028
  6.3.2 US IL-6 Inhibitors Market Size, 2017-2028
  6.3.3 Canada IL-6 Inhibitors Market Size, 2017-2028
  6.3.4 Mexico IL-6 Inhibitors Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe IL-6 Inhibitors Revenue, 2017-2028
  6.4.2 Germany IL-6 Inhibitors Market Size, 2017-2028
  6.4.3 France IL-6 Inhibitors Market Size, 2017-2028
  6.4.4 U.K. IL-6 Inhibitors Market Size, 2017-2028
  6.4.5 Italy IL-6 Inhibitors Market Size, 2017-2028
  6.4.6 Russia IL-6 Inhibitors Market Size, 2017-2028
  6.4.7 Nordic Countries IL-6 Inhibitors Market Size, 2017-2028
  6.4.8 Benelux IL-6 Inhibitors Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia IL-6 Inhibitors Revenue, 2017-2028
  6.5.2 China IL-6 Inhibitors Market Size, 2017-2028
  6.5.3 Japan IL-6 Inhibitors Market Size, 2017-2028
  6.5.4 South Korea IL-6 Inhibitors Market Size, 2017-2028
  6.5.5 Southeast Asia IL-6 Inhibitors Market Size, 2017-2028
  6.5.6 India IL-6 Inhibitors Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America IL-6 Inhibitors Revenue, 2017-2028
  6.6.2 Brazil IL-6 Inhibitors Market Size, 2017-2028
  6.6.3 Argentina IL-6 Inhibitors Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa IL-6 Inhibitors Revenue, 2017-2028
  6.7.2 Turkey IL-6 Inhibitors Market Size, 2017-2028
  6.7.3 Israel IL-6 Inhibitors Market Size, 2017-2028
  6.7.4 Saudi Arabia IL-6 Inhibitors Market Size, 2017-2028
  6.7.5 UAE IL-6 Inhibitors Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche IL-6 Inhibitors Major Product Offerings
  7.1.4 Roche IL-6 Inhibitors Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Regeneron Pharmaceuticals Inc.
  7.2.1 Regeneron Pharmaceuticals Inc. Corporate Summary
  7.2.2 Regeneron Pharmaceuticals Inc. Business Overview
  7.2.3 Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Major Product Offerings
  7.2.4 Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Revenue in Global Market (2017-2022)
  7.2.5 Regeneron Pharmaceuticals Inc. Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi IL-6 Inhibitors Major Product Offerings
  7.3.4 Sanofi IL-6 Inhibitors Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 Janssen Global Services LLC
  7.4.1 Janssen Global Services LLC Corporate Summary
  7.4.2 Janssen Global Services LLC Business Overview
  7.4.3 Janssen Global Services LLC IL-6 Inhibitors Major Product Offerings
  7.4.4 Janssen Global Services LLC IL-6 Inhibitors Revenue in Global Market (2017-2022)
  7.4.5 Janssen Global Services LLC Key News
7.5 Novimmune SA
  7.5.1 Novimmune SA Corporate Summary
  7.5.2 Novimmune SA Business Overview
  7.5.3 Novimmune SA IL-6 Inhibitors Major Product Offerings
  7.5.4 Novimmune SA IL-6 Inhibitors Revenue in Global Market (2017-2022)
  7.5.5 Novimmune SA Key News
7.6 UCB Pharma
  7.6.1 UCB Pharma Corporate Summary
  7.6.2 UCB Pharma Business Overview
  7.6.3 UCB Pharma IL-6 Inhibitors Major Product Offerings
  7.6.4 UCB Pharma IL-6 Inhibitors Revenue in Global Market (2017-2022)
  7.6.5 UCB Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. IL-6 Inhibitors Market Opportunities & Trends in Global Market
Table 2. IL-6 Inhibitors Market Drivers in Global Market
Table 3. IL-6 Inhibitors Market Restraints in Global Market
Table 4. Key Players of IL-6 Inhibitors in Global Market
Table 5. Top IL-6 Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 6. Global IL-6 Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global IL-6 Inhibitors Revenue Share by Companies, 2017-2022
Table 8. Global Companies IL-6 Inhibitors Product Type
Table 9. List of Global Tier 1 IL-6 Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IL-6 Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global IL-6 Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - IL-6 Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - IL-6 Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global IL-6 Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - IL-6 Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - IL-6 Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global IL-6 Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global IL-6 Inhibitors Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global IL-6 Inhibitors Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America IL-6 Inhibitors Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America IL-6 Inhibitors Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe IL-6 Inhibitors Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe IL-6 Inhibitors Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia IL-6 Inhibitors Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia IL-6 Inhibitors Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America IL-6 Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America IL-6 Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa IL-6 Inhibitors Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa IL-6 Inhibitors Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche IL-6 Inhibitors Product Offerings
Table 32. Roche IL-6 Inhibitors Revenue (US$, Mn), (2017-2022)
Table 33. Regeneron Pharmaceuticals Inc. Corporate Summary
Table 34. Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Product Offerings
Table 35. Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi IL-6 Inhibitors Product Offerings
Table 38. Sanofi IL-6 Inhibitors Revenue (US$, Mn), (2017-2022)
Table 39. Janssen Global Services LLC Corporate Summary
Table 40. Janssen Global Services LLC IL-6 Inhibitors Product Offerings
Table 41. Janssen Global Services LLC IL-6 Inhibitors Revenue (US$, Mn), (2017-2022)
Table 42. Novimmune SA Corporate Summary
Table 43. Novimmune SA IL-6 Inhibitors Product Offerings
Table 44. Novimmune SA IL-6 Inhibitors Revenue (US$, Mn), (2017-2022)
Table 45. UCB Pharma Corporate Summary
Table 46. UCB Pharma IL-6 Inhibitors Product Offerings
Table 47. UCB Pharma IL-6 Inhibitors Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. IL-6 Inhibitors Segment by Type in 2021
Figure 2. IL-6 Inhibitors Segment by Application in 2021
Figure 3. Global IL-6 Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global IL-6 Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global IL-6 Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by IL-6 Inhibitors Revenue in 2021
Figure 8. By Type - Global IL-6 Inhibitors Revenue Market Share, 2017-2028
Figure 9. By Application - Global IL-6 Inhibitors Revenue Market Share, 2017-2028
Figure 10. By Region - Global IL-6 Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Country - North America IL-6 Inhibitors Revenue Market Share, 2017-2028
Figure 12. US IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 13. Canada IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe IL-6 Inhibitors Revenue Market Share, 2017-2028
Figure 16. Germany IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 17. France IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 19. Italy IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Russia IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia IL-6 Inhibitors Revenue Market Share, 2017-2028
Figure 24. China IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. Japan IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. India IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America IL-6 Inhibitors Revenue Market Share, 2017-2028
Figure 30. Brazil IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa IL-6 Inhibitors Revenue Market Share, 2017-2028
Figure 33. Turkey IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Israel IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. UAE IL-6 Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. Roche IL-6 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi IL-6 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Janssen Global Services LLC IL-6 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novimmune SA IL-6 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. UCB Pharma IL-6 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)